Sensitivities of Uterine Adenocarcinoma, Mixed Mullerian Tumor (MMT) and Sarcoma Cell Lines to Chemotherapeutic Agents and a Flex-Het Drug
American Journal of Pharmacology and Toxicology · 2006
DOI: 10.3844/ajptsp.2006.83.86 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Pharmacology and Toxicology, 2006. Verfasst von Johnny Hyde und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190.
Förderung
- NCI NIH HHS
Zitieren
APA
Hyde, J., & Benbrook, D. M. (2006). Sensitivities of Uterine Adenocarcinoma, Mixed Mullerian Tumor (MMT) and Sarcoma Cell Lines to Chemotherapeutic Agents and a Flex-Het Drug. American Journal of Pharmacology and Toxicology. https://doi.org/10.3844/ajptsp.2006.83.86
Vancouver
Hyde J, Benbrook DM. Sensitivities of Uterine Adenocarcinoma, Mixed Mullerian Tumor (MMT) and Sarcoma Cell Lines to Chemotherapeutic Agents and a Flex-Het Drug. American Journal of Pharmacology and Toxicology. 2006. doi:10.3844/ajptsp.2006.83.86
BibTeX
@article{Hyde2006,
author = {Hyde, Johnny and Benbrook, Doris M},
title = {Sensitivities of Uterine Adenocarcinoma, Mixed Mullerian Tumor (MMT) and Sarcoma Cell Lines to Chemotherapeutic Agents and a Flex-Het Drug},
journal = {American Journal of Pharmacology and Toxicology},
year = {2006},
doi = {10.3844/ajptsp.2006.83.86}
}
EUVIMED